Neurosoft Bioelectronics garners $7.5M for brain-computer interface technology

Neurosoft Bioelectronics closed a $7.5 million seed funding round led by Skybound Venture Capital, bringing total funding to over $20 million. The company is developing minimally invasive brain-computer interface technology. The round was oversubscribed and included participation from IAG Capital Partners, Connecticut Innovations, and PL Capital.